Refers to the property of a substance or treatment or agent that reduces inflammation.
CBD antagonism is demonstrated as an anticonvulsant effect. CBD increases endocannabinoid expression so can also indirectly affect inflammation and redox balance via these molecules.
The latest research (2024) on CBD’s anti-inflammatory properties offers potential benefits in reducing chronic inflammation related to a number of health conditions.
CBD’s interaction with the body’s endocannabinoid system (ECS) is pivital in its potential effects on inflammation. The ECS regulates many physiological processes including immune response and inflammation.
CBD impacts the ECS receptors, potentially influencing the body’s inflammatory response. For example CBD may inhibit the absorption of anandamide, an endocannabinoid known to regulate pain. This could result in reduced inflammatory responses in the body.
It seems clear that CBD has the potential to be effective for inflammation.